2Ojeh NO, Frame JD, and Navsaria HA. 2001, In vitro characterization of an artiffwial dermal scaffold , Tissue Engirueering, 7:457 - 472.
3Ingham E, Matthews JB, Kearney JN, et al. 1993, The Effects of cryopreseroation protocols on the immunogenicity of allogenceic skin grafts. Cryobiology, 30 ( 5 ) : 443 -458.
4Ben-Bassat H, Strauss N, Ron M, et al. 1996, Transplantation performance of human skin cryopresemmd by programmed or stepurise freezing and stored at - 80 degrees C or - 180 degrees C. J Burn Care Rehabil, 17 (5) :421 - 428.
6Dawn RA, Kang L, Jonathan M. 1999, Practical Considerations for Large-scale Cryopreservatlon of a Tissue Engineered Human Dermal Replacement. Advances inHeat and Mass Transfer in Biotechnology, 44:71 - 91.
7Jonathan M ,Kang L ,Patch R, et al. 1998, Three-dimensional fibroblast culture implant for the treatment of diabetic foot ulcers: metabolic activity and therapeuticrange. Tissue Eng ,4(4) :403 - 414.
8Phillips TJ. New skin for old:Development in biological skin substitutes. Arch Dermatol 1998; 134(3):344-9
